MYLAN Sirdupla Quick Start Manual Download Page 2

*Seretide

®

, Evohaler

®

 and AeroChamber Plus

®

 are registered trade marks of 

Glaxo Group Limited

Do cover up.

Do take your time.

Do go online.

Keep dust, dirt and anything else that gets into your pocket 
away from the mouthpiece. Use the cover provided.

Breathe slowly before using your inhaler. It may help
to stand in front of a mirror for the first few times.

You can find a full set of instructions for using your 
inhaler at 

sirdupla.mylan.co.uk

.

Some Sirdupla

 must-do’s

Things you should know 

about Sirdupla

(salmeterol xinafoate/fluticasone propionate)

2

1

4

5

3

Sirdupla™ is a therapeutic equivalent of Seretide

®

*  

Evohaler

®

*at equivalent strengths. Sirdupla

TM  

is not 

available in all the same strengths.

The colour of the device may be different than what you   
are used to, but it delivers the medication the same way. 

Sirdupla

TM  

should be used in patients aged 18 years and 

over with moderate to severe asthma.

Sirdupla

TM  

includes a built-in automated dose-by-dose 

counter to help you stay on track with treatment.

If a Spacer device is required only the Aerochamber Plus

®

 

spacer should be used

.

Reporting of side effects:
If you get any side effects, talk to your doctor, pharmacist or 
nurse. This includes any possible side effects not listed in the 
package leaflet. You can also report side effects directly via 
the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more  
information on the safety of this medicine.
Side effects should also be reported to Medical Information, 
Mylan, Building 4, Trident Place, Mosquito Way, Hatfield, 
Hertfordshire, AL10 9UL. 

Date of preparation: July 2018

Job code: SIR-2018-0022

080 0 1218267  
[email protected]

Important contact numbers 

for further information;

Doctor

Nurse 

Pharmacist

Sirdupla

(salmeterol xinafoate/fluticasone propionate)
Sirdupla

TM

 is indicated in 

adults

 18 years of age 

and older for the regular treatment of asthma where 

use of a combination product (long-acting 

β

2 agonist 

and inhaled corticosteroid) is appropriate. Sirdupla

TM

 

should not be used for patients with mild asthma.

A guide for patients 

prescribed Sirdupla

Reviews: